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Signiﬁcant controversy exists regarding the impact of hematopoietic stroma damage by irradiation on the
efﬁciency of engraftment of intravenously transplanted stem cells. It was previously demonstrated that in
normal syngenic mice, all intravenously transplanted donor stem cells, present in the bone marrow, compete
equally with those of the host. In this study, we comprehensively compared the blood cell production derived
from transplanted donor stem cells with that from the host stem cells surviving various doses of sub-
myeloablative irradiation. We compared the partial chimerism resulting from transplantation with theoretical
estimates that assumed transplantation efﬁciencies ranging from 100% to 20%. The highest level of consensus
between the experimental and the theoretical results was 100% for homing and engraftment (ie, the utilization
of all transplanted stem cells). These results point to a very potent mechanism through which intravenously
administered hematopoietic stem cells are captured from circulation, engraft in the hematopoietic tissue, and
contribute to blood cell production in irradiated recipients. The damage done to hematopoietic stroma and to
the trabecular bone by submyeloablative doses of ionizing radiation does not negatively affect the homing and
engraftment mechanisms of intravenously transplanted hematopoietic progenitor and stem cells.
 2013 American Society for Blood and Marrow Transplantation.INTRODUCTION negative bystander effect [19], and bonemarrow stroma cells
Transplantation of hematopoietic stem cells (HSCs) is
a potentially curative procedure for a variety of malignant,
congenital, and autoimmune diseases. It is based on the
ability of HSCs to self-renew and differentiate inmultilineage
hematopoiesis and from the potential of HSCs to survive
separation from their original microenvironment niche.
Additionally, transplanted HSCs recognize recipient marrow
and engraft into it after being introduced into the circulation
(homing) and integrate with the host hematopoiesis and its
controlling mechanisms (engraftment).
Several experimental studies attempted to determine the
efﬁcacy of transplanted HSC homing and engraftment. When
normal mice were given different doses of bone marrow
cells (BMCs) from syngenic donors, all transplanted HSCs
engrafted and apparently replaced a portion of those of the
host [1-3]. In contrast, this almost absolute efﬁciency of HSC
transplantation in normal mice was not found in other
studies, which used lethally irradiated mice as the recipients
of HSC transplants [4-10]. The signiﬁcantly lower efﬁciency
of homing and engraftment of HSCs transplanted to irradi-
ated mice has been attributed to the bone marrow damage
elicited by irradiation that affects the endothelium of bone
marrow sinusoids [11-14] and osteoblasts [15]. Even rela-
tively low submyeloablative doses of gamma radiation
damage the trabecular bone and acutely reduce its endosteal
surface as demonstrated by increased intertrabecular
distances [16,17]. The trabecular bone was shown to be the
major site for the homing and engraftment of transplanted
stem cells [18]. Murine bone marrow exposed to myeloa-
blative irradiation damages transplanted HSCs by an acuteedgments on page 718.
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13.02.012express senescence markers [20]. It is therefore of interest
that several studies [21-23] concluded that in irradiated
mice, virtually all transplanted HSCs engraft.
We studied the engraftment efﬁciency of intravenously
administered donor HSCs to mice subjected to progressive
submyeloablative doses of irradiation to test whether
different levels of microenvironmental damage will nega-
tively inﬂuence capturing and engraftment of transplanted
HSCs. Our results demonstrate that intravenously adminis-
tered progenitors and HSCs engraft in submyeloablatively
irradiated congenic mice quantitatively and with a very high
efﬁciency. Hence, the microenvironmental damage caused
by a wide range of radiation doses does not signiﬁcantly
disturb transplantation of HSCs. We also show that in the
syngenic setting, donor progenitors and HSCs that were
disrupted from their niches are equal in terms of blood cell




C57BL/6NCrl mice (CD45.2) and congenic B6.SJL-Ptprca Pepcb/BoyJ mice
(CD45.1) were bred in a speciﬁc pathogen-free barrier area of the institu-
tional animal facility and maintained in a clean conventional part of the
facility during the experiments. Three- to 6-month-old mice were used in
the experiments. All experiments were approved by the Laboratory Animal
Care and Use Committee of the First Faculty of Medicine, Charles University
in Prague and were performed in accordance with national and interna-
tional guidelines for laboratory animal care.
Irradiation
Total body irradiation of w.58 Gy/min from a 60Co source from
a distance of 123.5 cm was used.
Bone Marrow Collection and Transplantation
BMCs were collected from the femurs of mice sacriﬁced by cervical
dislocation. Femurs were repeatedly ﬂushed with 1 mL phosphate-buffered
saline (pH 7.5) þ .5% bovine serum albumin (hereafter referred to as PBS-
BSA) using a 25-G needle. The cells were counted with a CellometerTransplantation.
Figure 1. Survival of STRCs and LTRCs after irradiation with various doses. (A) Experimental data. (B) Derivation of the proportional survival estimates. Data
are presented as mean  SE of the mean (n ¼ 3). Regression analysis: nonlinear regression using the log (inhibitor) versus response curve e variable slope
(4 parameters) calculation.
Figure 2. Schematic representation of experiments for determining depen-
dence of donor chimerism on submyeloablative conditioning irradiation of
host congenic mice. *Average from estimates derived from chimerism deter-
mined in blood and bone marrow (see Figure 1B).
K. Forgacova et al. / Biol Blood Marrow Transplant 19 (2013) 713e719714(Nexcelom Bioscience, Lawrence, MA). Usually, an aliquot containing BMCs
fromaone-half femurwas intravenously administered to congenic normal or
irradiated recipients. The average cellularity of the bone marrow obtained
from 1 femur was 29.4 5.13 in normal male mice and 28.74.91 in normal
female mice. BMCs were administered intravenously into the retro-orbital
venous plexus in a volumeof .5mL.Most recipient groupswere of 3 to 5mice.
Donor Chimerism Analysis
A sample of heparinized peripheral blood was taken from the retro-
orbital venous plexus from 2 weeks to 6 months after transplantation to
distinguish the chimerism arising from the short-term repopulating cells
(STRCs; chimerism level determined in blood after 2 weeks or 1 month) and
long-term repopulating cells (LTRCs; chimerism level determined in blood
or bone marrow after 3 and more months) as described previously [24].
Brieﬂy, 50-mL blood samples were added to 3 mL ammonium chloride lysing
buffer (.15 M NH4Cl, .035 M NaCl, and .1 mM EDTA) and agitated at 37C for
15 minutes to lyse the red blood cells, then washed twice with PBS-BSA,
resuspended in 100 mL PBS-BSA, and stained with PE-conjugated anti-
CD45.1 and FITC-conjugated anti-CD45.2 antibodies (both BioLegend, San
Diego, CA) for 30 minutes on ice in the dark. BMCs were collected from the
femurs into 1 mL PBS-BSA. Twenty microliters of the cell suspension was
added to 3 mL PBS-BSA and centrifuged (4C, 400g, 6 minutes). After
removing the supernatant, the cells were stained as described previously.
After washing with PBS-BSA, samples were analyzed by ﬂow cytometry
(FACS Canto II, BD Biosciences, San Jose, CA). A gating for CD45.1þ and
CD45.2þ cells was performed. CD45.1þ/CD45.2þ artiﬁcial doublets, if
present, were omitted from the analysis.
Calculation of Theoretical Donor Chimerism
Average total bone marrow cellularity determined in 13 published
studies on mice was 349  115 (SD) million [25]. BMCs collected from 1
femur (average of 29 million) in the present experiments would then
represent 8.3% of the total BMCs. Boggs [26] determined the fraction of
marrow cells in 1 femur to represent 6.7% of their total number. Therefore,
we assumed that the BMCs in 1 femur represented 7% of the total cells and
contained 7% of the total pool of STRCs and LTRCs. The calculated donor
chimerism level assumed that either all transplanted repopulating cells
engrafted and contributed to blood cell production equally to those
surviving in submyeloablatively irradiated hosts (100% efﬁciency) or the
efﬁciency of engraftment was only 80%, 60%, 40% or 20%. The calculation for
the theoretically expected chimerism used the following formula: % of the
donor chimerism ¼ % of the donor repopulating cells administered/[% of the
donor repopulating cells administered þ % of the host repopulating cells
surviving irradiation]  100.
Statistical Analyses
Statistical analyses were performed with the software GraphPad Prism
(GraphPad Software, San Diego, CA, www.graphpad.com). Data arepresented as the mean SE of the mean. The log (inhibitor) versus response
curve e variable slope (4 parameters) calculation using a least-squares ﬁt
was used for the nonlinear regression of radiation dose-dependence data.
A least-squares ﬁt was also used to compare the conformity of the experi-
mental data with the calculated data.RESULTS
Survival of STRCs and LTRCs after Irradiation
To determine the fraction of host repopulating cells
surviving different doses of irradiation, groups of 3 CD45.2
mice were irradiated with .5 Gy, 1 Gy, 2 Gy, 3 Gy, 4 Gy, 5 Gy,
6 Gy, and 7 Gy. The control group (0 group) was not irradi-
ated. BMCs were collected 22 hours after irradiation and
transplanted in an amount corresponding to a one-half
femur to CD45.1 recipients preconditioned with a uniform
submyeloablative radiation dose of 5 Gy 2 hours before
transplantation. Blood samples (peripheral blood) were
Figure 3. Donor chimerism determined after 1 month (STRCs) in peripheral blood (PB) and after either 4 (A, B) or 6 (C, D) months (LTRCs) in peripheral blood and
bone marrow (BM) in progressively irradiated recipients transplanted with a standard dose of normal bone marrow cells (see Figure 2). Data are presented as
mean  SE of the mean (n ¼ 5). Regression analysis: nonlinear regression using the log (inhibitor) versus response curve e variable slope (4 parameters) calculation.
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after the transplantation to determine donor chimerism,
which was also determined after 6 months (LTRCs) in bone
marrow (Figure 1A; the results obtained after 3 months were
similar to those determined after 6 months and are not
shown). Survival of STRCs and LTRCs was proportional to
progressive doses of irradiation and showed higher radio-
sensitivity of STRCs, especially after lower doses.
The engraftment of the marrow from nonirradiated
donors (0 group) was taken to be 100% (chimerism 54.7% for
STRCs and 73.3% for LTRCs) to estimate the surviving frac-
tions of STRCs and LTRCs after irradiationwith various doses.
The chimerism values presented in Figure 1A were corrected
by a factor of 1.828 (100%/54.7%) for STRCs and 1.362 (100%/
73.4%) for LTRCs. A least-squares ﬁt was used for the
nonlinear regression of the radiation dose e chimerismdependence data. The obtained curves were used to estimate
the proportional survival of STRCs and LTRCs after various
doses of irradiation (Figure 1B).
Calculated (Theoretical) Chimerism after a Standard Dose
of Donor Cells
Irradiation reduces the pool of hematopoietic progenitors
and stem cells in recipient mice that competes with the pool
of transplanted donor cells. By determining the degree of this
reduction after different doses of irradiation (Figure 1B), it
was possible to calculate the expected (theoretical) engraft-
ment of transplanted STRCs and LTRCs administered in
a standard dose corresponding to 3.5% of their total pool in
normal nonirradiated bone marrow (Figure 2). Because 2
independent measurements of donor chimerism were
available from every experiment at 6 months after
Figure 4. Pooled results from the 4 separate experiments presented in Figure 3 (empty circles and solid curve) plotted against curves showing the theoretically
expected chimerism corresponding to 100%, 80%, 60%, 40%, and 20% engraftment efﬁciency derived from calculated data presented in Table S1 (dashed curves).
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marrow, a mean value from both survival estimates was used
in the calculations (Figure 2). The calculations used the
formula given in Methods and assumed efﬁciencies of donor
STRCs and LTRCs engraftment ranging from 100% (ie, 3.5% of
the donor marrow pool of repopulating cells engrafted) to
20% (Table S1).
Experimental Chimerism after a Standard Dose of Donor
Cells
To compare calculated donor chimerism levels with real
ones obtained experimentally, we performed 4 experiments
in which marrow cells from one-half femurs of normal
donors, representing 3.5% of total bone marrow, were
intravenously injected into congenic progressively irradiated
mice. The donor chimerism was determined after 1 month
(STRCs) and after 4 or 6 months (LTRCs). At the end of the
experiments, either after 4 months or after 6 months, donor
chimerismwas determined both in the peripheral blood and
in the bone marrow (Figure 3).
Comparison of Calculated (Theoretical) and Experimental
Engraftment Results
The results of the 4 separate experiments were pooled,
nonlinear regression curves were plotted through the pooled
data, and they were compared with the curves similarly
derived from the calculated estimates presented in Table S1
(Figure 4). The best ﬁt between the experimental and theo-
retical data was for the calculations assuming 100%
engraftment efﬁciency.
We further established how the ﬁt between the experi-
mental and the calculated data assuming 100% efﬁciency
would be affected by the variation in the fraction of BMCsFigure 5. Pooled results from the 4 separate experiments presented in Figure 3 (emp
pected chimerism corresponding to 100% engraftment efﬁciency and the bone marrowcontained in a one-half femur. This was assumed to be 3.5% of
the total marrow in all previous calculations. We calculated
a theoretical donor chimerism assuming a 100% engraftment
efﬁciency of transplanted donor STRCs/LTRCs but with their
content in a one-half femur ranging from 2.5% to 4.5% of their
total marrow number (Table S2). Curves were plotted
through the obtained data and are presented in Figure 5,
together with the chimerism data from real experiments.
There was a relatively low impact of the variation in fractions
of STRCs and LTRCs contained in a one-half femur between
3% and 4.5% on the results (Figure 5, Table S2).
Calculated (Theoretical) and Experimental Chimerism
after Different Doses of Donor Cells
Additional experiments used progressively irradiated
recipients as in previous experiments but transplanted with
a different fraction of normal congenic marrow ranging from
14.0% to .9% of its total murine content. The results of 2
experiments were pooled and are presented in Table 1. There
was a signiﬁcant correlation between experimental and
calculated donor chimerism levels that assumed a 100%
engraftment efﬁciency.
Stability of Partial Chimerism in Submyeloablatively
Irradiated Mice Transplanted with Normal Bone Marrow
To test whether the HSCs surviving irradiation in bone
marrow are equal in blood cell production to the donor HSCs
that were not irradiated but were disrupted from their niches
and intravenously transplanted, we compared the stability of
partial chimerism during a 3-month period in 21 experi-
ments (Table 2). A possible compromised ﬁtness of donor
LTRCs in blood cell production should manifest itself as
a predominance of the one with better ﬁtness over the otherty circles and solid curve) plotted against curves showing the theoretically ex-
from a one-half femur representing from 2.5% to 4.5% of total marrow cells.
Table 1
Calculated and Experimentally Determined Donor Chimerism after Transplantation of Various Fractions of Marrow from Normal Donors to Progressively
Irradiated Recipients
Donor BMCs Transplanted Recipient Irradiation (Gy)
Estimated Fraction of STRCs Survived (%)
1 Gy 2 Gy 3 Gy 4 Gy 5 Gy 6 Gy
52% 26% 13% 6% 1.5% .20%
Estimated fraction of STRCs
transplanted (%)
2f w 14.00% (21) 9 (35) 28 (52) 44 (70) 77 d d
1f w 7.00% d (21) 21 (35) 26* (54) 58* (82) 88 d
.5f w 3.5% d (12) 16 (21) 19* (37) 44* (70) 78* (95) 92*
.25f w 1.75% d d d (23) 49 (54) 64* (90) 84*
.125f w .90% d d d d (38) 64 (82) 80*
Groups of 5 mice, either CD45.2 or CD45.1, were irradiated with doses of 1 Gy to 6 Gy. Two hours later, the mice were injected with congenic marrow in an
amount ranging from the equivalent of .125 to 2 femurs. The calculated (theoretical) donor chimerism level (numbers in italics and parentheses) was calculated
assuming a 100% engraftment efﬁciency of donor STRCs. The experimental chimerism (numbers in bold) was determined 5 weeks after transplantation in
peripheral blood. The correlation coefﬁcient between the calculated and the experimental values was r ¼ .9227 (P < .0001).
* Mean from 2 experiments that used opposing combinations of CD45.1 and CD45.2 mice as donors and recipients; the remaining data are from a single
experiment.
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tion [27]. The results presented in Table 2 indicate an equal
ﬁtness of the competing donor and host LTRCs during the 3-
month period.
DISCUSSION
HSCs migrate from the blood circulation during embry-
onic and fetal development to their ﬁnal destination in the
bonemarrow. This migration continues in adulthood at a low
intensity, in the mouse establishing a ﬂow of progenitors to
the spleen and exchanging HSCs between different parts of
the bonemarrow [28]. The engraftment of donor progenitors
and HSCs intravenously administered to normal mice indi-
cated the existence of homing and engraftment mechanisms
for HSCs and progenitors operating in undamaged hemato-
poietic tissue [29-32]. Subsequent studies showed that
labeled marrow cells, highly enriched in HSCs, were visual-
ized in the trabecular bone of the calvaria 20 minutes after
their injection to peripheral blood [33]. Several studies
demonstrated that essentially all transplanted progenitor
cells and HSCs engraft in normal syngenic mice and replace
a corresponding fraction of the host’s cells in the process of
blood cells production [1-3,34].
Lethal doses of irradiation destroy all hematopoietic cells
and damage bone marrow stroma [11,14,15,20]. Irradiated
bone marrow may also damage transplanted HSCs by
a bystander effect [19]. Several studies that used lethally
irradiated mice as recipients of transplanted hematopoietic
cells, variously enriched in progenitors and stem cells, found
a homing and engraftment efﬁciency in the range of 10% to
50% [4-10]. The homing was 100% in the recent experimentsTable 2







Ratio at 3 to 6
Months
n
4 Gy 58.2  10.28 52.70  9.78 1.13  .01 5
5 Gy 87.20  6.872 85.53  8.58 1.02  .03 3
6 Gy 89.48  1.488 88.35  1.96 1.02  .014 13
Recipient mice, either CD45.2 or CD45.1, were irradiated (total body) with
a submyeloablative dose of ionizing radiation 4 Gy, 5 Gy, or 6 Gy and
underwent transplantation with congenic donor BMCs. Donor chimerism
was determined in peripheral blood after 3 and 6 months. Values are
means  SE of the mean.of Shen et al. [19]. Direct visualization of labeled cells, highly
enriched in HSCs and intravenously injected into lethally
irradiated recipients, revealed that they reached the endos-
teal bone surface after 20 minutes, similarly to nonirradiated
recipients, but they localized closer to the bone surface and
then started to proliferate [19,33]. Hence, although lethal
irradiation may decrease the homing of HSC donor marrow
cells to the host bone marrow [4-8], it still allows the
engraftment of transplanted HSCs and stimulates their
proliferation.
Transplantation to submyeloablatively irradiated mice,
compared with lethally irradiated mice, enables application
of the approach originally introduced for determination of
the transplantation efﬁciency in normal nonmyeloablated
mice [1-3,34,35]. However, this requires knowledge of the
proportional survival of HSCs in recipients irradiated before
receiving a deﬁned dose of competing donor HSCs. Further-
more, activity with which the competing host and donor
HSCs contribute to the production of blood cells should not
signiﬁcantly differ.
Therefore, we ﬁrst determined the proportional survival
of hematopoietic STRCs and LTRCs in progressively irradiated
mice. The survival of STRCs and LTRCs differed (Figure 1A),
conﬁrming a higher radiosensitivity of STRCs, especially after
low doses [36,37]. Ionizing radiation induces double-strand
DNA breaks, and LTRCs and STRCs differ in their capacity
for non-homologous end-joining repair mechanism. This
enables the survival of LTRCs after doses, which result in the
apoptosis of progenitors (STRCs) [38,39].
We next compared the activity of the competing host and
donor HSCs by examining the stability of the partial donor
chimerism in submyeloablatively irradiated mice between 3
and 6 months after irradiation and transplantation (Table 2).
The results indicated the functional equivalence of the
competing donor and host LTRCs during the period of 3
months.
Using congenic mice to enable the discrimination of
donor and host cells in chimeric mice by their CD45.1/CD45.2
isoforms expressed on most hematopoietic cells, we trans-
planted a standard dose of normal marrow cells corre-
sponding to approximately 3.5% of their total content in the
mouse to progressively irradiated recipients. The resulting
donor chimerism was determined after 1 month and after 4
to 6 months. The results were compared with theoretical
K. Forgacova et al. / Biol Blood Marrow Transplant 19 (2013) 713e719718chimerism levels calculated with the assumption that from
100% to 20% of the transplanted STRCs and LTRCs engrafted
and contributed just as much to the production of blood cells
as those surviving irradiation in the hosts. The highest
agreement between experimental and theoretical data was
constant for calculations assuming 100% utilization of donor
STRCs and LTRCs in recipients irradiated with 3 Gy and
higher doses. This result was further veriﬁed in 2 experi-
ments in which different doses of donor marrow cells were
administered to progressively irradiated hosts.
The efﬁciency seemed to be lower in recipients irradiated
with doses lower than 3 Gy. Using CD45.1/CD45.2 congenic
mice, Tomita et al. [40] also demonstrated that stable
chimerism was uniformly established in 3-Gy-irradiated
CD45.2 recipients of CD45.1 BMCs but not in 1.5-Gy-irradi-
ated recipients. van Os et al. [41] demonstrated immunoge-
nicity of Ly5 (CD45) antigens in transplantation experiments.
The immunosuppressive treatment applied to normal
recipients of congenic BMCs signiﬁcantly increased donor
chimerism (Table S3). Hence, the lower than expected
engraftment of transplanted marrow in recipients irradiated
by doses lower than 3 Gy was likely due to the minor
immune disparity of CD45.1/CD45.2 congenic mice.
In conclusion, this study demonstrates that virtually all
intravenously transplanted hematopoietic progenitor and
stem cells are captured in the hematopoietic tissue of con-
genic mice irradiated with a wide range of submyeloablative
doses and produce blood cells equally to those surviving
irradiation. The homing and engraftment mechanisms of the
circulating HSCs that operate in normal mice are thus fully
preserved when hematopoiesis is damaged by a pre-
conditioning treatment disrupting its marrow microvascu-
lature, stroma cells, and the trabecular bone. This very high
efﬁciency with which donor progenitors and HSCs engraft in
submyeloablatively irradiated recipients provides an expla-
nation for the failure to enhance the process pharmacologi-
cally [42]. The highly quantitative relationship between HSCs
present in the host to those contained in a standard dose of
transplanted congenic marrow also provides an experi-
mental tool for estimating the number of HSCs without their
transplantation. Most important, further research focusing
on the elucidation of the highly efﬁcient mechanisms of
intravenously transplanted HSCs should provide new
insights into HSC biology.ACKNOWLEDGMENTS
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